Skip to content
10-Q

Quarterly Report

PEGASUS MEDICAL HOLDINGS, INC.

0001140361-21-037865

← back to feed
Filed
Nov 15, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Oct 31, 2021 1M sh
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$24.32K
Operating Cash Flow Q3 2021 · Sep 30, 2020 $14.75K
Cash And Equivalents Q3 2021 · Sep 30, 2021 $19.2K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $43.51K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $43.87K
Cash And Equivalents Q3 2021 · Dec 31, 2019 $29.12K
Stockholders Equity Q3 2021 · Sep 30, 2021 $12.03K
Stockholders Equity Q3 2021 · Dec 31, 2020 $8.34K
Stockholders Equity Q3 2021 · Sep 30, 2020 $9.76K
Stockholders Equity Q3 2021 · Dec 31, 2019 $10.89K
Current Liabilities Q3 2021 · Sep 30, 2021 $7.17K
Current Liabilities Q3 2021 · Dec 31, 2020 $35.17K
Current Assets Q3 2021 · Sep 30, 2021 $19.2K
Current Assets Q3 2021 · Dec 31, 2020 $43.51K
Total Assets Q3 2021 · Sep 30, 2021 $19.2K
Total Assets Q3 2021 · Dec 31, 2020 $43.51K
Net Income Q3 2021 · Sep 30, 2021 −$860
Net Income Q3 2021 · Sep 30, 2021 −$31.32K
Net Income Q3 2021 · Sep 30, 2020 −$360
Net Income Q3 2021 · Sep 30, 2020 −$1.13K